The question of how memories are lost remains a major focus of memory and sleep research. Using techniques like MRI and EEG, Helene Benveniste, MD, PhD, professor of anesthesiology, and her colleagues have found that sleep may allow the brain critical time and conditions to remove waste metabolites. The accumulation of certain metabolites in the brain, in particular beta-amyloid and abnormal tau proteins, seems to increase the risk of cognitive disorders like AD.
Benveniste said researchers once thought the primary purpose of sleep is to allow rest and memory processing. “Now I think we’re understanding another purpose of sleep may also be to give the brain time to clean itself,” she said.
In 2013 Benveniste helped to initially describe the glymphatic system, a waste-removal pathway in the brain that acts like the lymphatic system but relies largely on astroglial brain cells. In a nutshell, the glymphatic system allows cerebrospinal fluid to flow into the spaces around arteries before passing through aquaporin-4 (AQP4) water channels into brain tissues, where it mixes with fluids and metabolic waste around cells, and then moves out of brain tissues into the space surrounding veins for clearance through the lymphatic or circulatory system.
Benveniste and others have found evidence that healthy glymphatic function may reduce the effects of risk factors implicated in cognitive conditions like AD by facilitating metabolic waste clearance in the brain. A study she worked on in 2018 concluded that even one night of sleep deprivation increases beta-amyloid burden in the right hippocampus of adults.
Some studies, including several Benveniste co-authored, also show that many people with AD, or cognitive impairment from vascular dementia or small-vessel disease, experience glymphatic dysfunction. The system also seems to be most efficient during sleep, in particular slow-wave sleep (SWS). “By far the biggest differences we’ve seen in glymphatic transport rates are when people go from being awake to asleep,” Benveniste explained, adding that medications which manipulate arousal states like anesthetics also seem to heavily influence glymphatic function.
Factors that influence circulation also appear to affect glymphatic function, including pulse rate, breathing rate, and some metabolic conditions. Benveniste and others have also found that glymphatic efficiency improves when rats and other subjects sleep lying on their sides or backs. She noted these positions are the preferred sleeping posture in many animals, including humans.
“This is something I find very interesting clinically,” Benveniste said. “People in the ICU that have trouble swallowing or protecting their airways or have brain trauma are often kept seated with the head raised—even while sleeping. Sometimes we even interrupt sleep frequently for checking up on them.” With a better understanding of sleep and glymphatic function, Benveniste explained, practices like these may be revised.